Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization

In interstitial lung disease (ILD), pulmonary hypertension (PH) is a major adverse prognostic determinant. Transthoracic echocardiography (TTE) is the most widely used tool when screening for PH, although discordance between TTE and right heart catheter (RHC) measured pulmonary haemodynamics is increasingly recognized. We evaluated the predictive utility of the updated European Society of Cardiology/European Respiratory Society (ESC/ERS) TTE screening recommendations against RHC testing in a large, well‐characterized ILD cohort.

[1]  R. Dweik,et al.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis. , 2016, Respiratory medicine.

[2]  J. Behr,et al.  Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias , 2015, PloS one.

[3]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[4]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[5]  Dilip Pillai,et al.  Limitations and Strengths of Doppler/Echo Pulmonary Artery Systolic Pressure–Right Heart Catheterization Correlations: A Systematic Literature Review , 2015, Echocardiography.

[6]  Sanjiv J Shah,et al.  Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. , 2011, Chest.

[7]  R. Baughman,et al.  Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. , 2010, Chest.

[8]  James N Kirkpatrick,et al.  Accuracy of noninvasively determined pulmonary artery systolic pressure. , 2010, The American journal of cardiology.

[9]  G. Giannakoulas,et al.  Elevated brain natriuretic peptide predicts mortality in interstitial lung disease , 2010, European Respiratory Journal.

[10]  D. Hansell,et al.  Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension , 2009, Thorax.

[11]  S. Nathan,et al.  Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. , 2008, Respiratory medicine.

[12]  D. Hansell,et al.  Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.

[13]  S. Nathan,et al.  Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. , 2008, Chest.

[14]  A. Karlamangla,et al.  Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. , 2007, Respiratory medicine.

[15]  J. Kirkpatrick,et al.  Reappraisal of the use of inferior vena cava for estimating right atrial pressure. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  P. Pellikka,et al.  The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. , 2005, Chest.

[17]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[18]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[19]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[20]  M. Sutton,et al.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.

[21]  J. Curtis,et al.  Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery. , 1998, Chest.

[22]  J. Pontén.  Pulmonary artery catheterisation , 1997, Acta anaesthesiologica Scandinavica. Supplementum.

[23]  L. B. Cook,et al.  Pulmonary artery catheterisation. , 1994, Annals of the Academy of Medicine, Singapore.

[24]  A. Torbicki,et al.  Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. , 1991, European heart journal.

[25]  N. Schiller,et al.  Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. , 1990, The American journal of cardiology.

[26]  J. Seward,et al.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.

[27]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[28]  P. Yock,et al.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.

[29]  H. Collard,et al.  Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy? , 2017, Respiratory medicine.

[30]  Standardized lung function testing. Official statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.